Chang Tu
Impact in
- Rheumatology top 10%
- Osteoarthritis Treatment and Mechanisms
-
- Cancer-related molecular mechanisms research
Papers in
-
- Angiogenesis and VEGF in Cancer 6
- Glycosylation and Glycoproteins Research 2
- Natural product bioactivities and synthesis 2
- Peroxisome Proliferator-Activated Receptors 2
-
- Osteoarthritis Treatment and Mechanisms 6
- Co-authors
- Hua Wu (9 shared papers)Yifan Xiao (10 shared papers)Jiyuan Yan (9 shared papers)Zhen Yang (4 shared papers)Jie‐Mei Wang (3 shared papers)Jun Tao (5 shared papers)Mingyu Song (3 shared papers)Shirong Pan (1 shared paper)
- Journals
- Stem Cell Research & Therapy (4 papers)Frontiers in Pharmacology (3 papers)Frontiers in Cardiovascular Medicine (2 papers)Microchimica Acta (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited Kingdom
In The Last Decade
Chang Tu
28 papers receiving 545 citations
Peers
Comparison fields: 5 of 87
- Rheumatology 88
- Cancer Research 63
- Biomaterials 59
- Molecular Biology 236
- Biophysics 16
Countries citing papers authored by Chang Tu
This map shows the geographic impact of Chang Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Tu more than expected).
Fields of papers citing papers by Chang Tu
This network shows the impact of papers produced by Chang Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Tu. The network helps show where Chang Tu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chang Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 62 | |
| 2 | 2006 | 58 | |
| 3 | 2006 | 50 | |
| 4 | 2021 | 40 | |
| 5 | 2016 | 36 | |
| 6 | 2018 | 30 | |
| 7 | 2020 | 30 | |
| 8 | 2019 | 30 | |
| 9 | 2019 | 28 | |
| 10 | 2022 | 27 | |
| 11 | 2007 | 26 | |
| 12 | 2019 | 23 | |
| 13 | 2021 | 18 | |
| 14 | 2021 | 15 | |
| 15 | 2020 | 14 | |
| 16 | 2005 | 12 | |
| 17 | 2024 | 8 | |
| 18 | 2021 | 7 | |
| 19 | 2021 | 7 | |
| 20 | 2020 | 7 |
About Chang Tu
Chang Tu is a scholar working on Molecular Biology, Rheumatology, Cancer Research, Pharmacology and Epidemiology, having authored 31 papers that have together received 550 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (6 papers), Angiogenesis and VEGF in Cancer (6 papers), Nitric Oxide and Endothelin Effects (3 papers), NF-κB Signaling Pathways (3 papers), Glycosylation and Glycoproteins Research (2 papers), Pregnancy and preeclampsia studies (2 papers), Natural product bioactivities and synthesis (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). The work is most often cited by research in Rheumatology (88 citations), Cancer Research (63 citations), Biomaterials (59 citations), Molecular Biology (236 citations) and Biophysics (16 citations). Chang Tu has collaborated with scholars based in China and United Kingdom. Frequent co-authors include Hua Wu, Yifan Xiao, Jiyuan Yan, Zhen Yang, Jie‐Mei Wang, Jun Tao, Mingyu Song, Shirong Pan, Xiangyu Tang and Chaoxu Liu. Their work appears in journals such as Stem Cell Research & Therapy, Frontiers in Pharmacology, Frontiers in Cardiovascular Medicine, Microchimica Acta and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.